Living with treatment-resistant depression can be incredibly challenging, but a new depression treatment is providing promising results for those who have struggled to find relief. Transcranial magnetic stimulation (TMS), although not a new method, has been gaining attention for its effectiveness in treating what psychiatrists call “treatment-resistant depression.”
TMS works by delivering a series of pulses to the brain’s neural circuitry, providing an energy boost that helps the brain utilize neurotransmitters to alleviate symptoms of depression. While the idea of stimulating the brain may sound intimidating, the treatment itself is not as scary as it may seem. TMS therapy has been FDA-approved for over a decade and has been shown to significantly reduce symptoms of depression.
One of the challenges TMS faces is the lack of awareness among the general public. Many people living with depression may not be aware of this treatment option. Dr. Suzanna Jasberg, a senior director of adult psychiatry, emphasizes the importance of spreading the word about TMS so that more individuals can benefit from its potential.
The treatment is time-consuming, requiring daily sessions for six weeks, but the results are promising. Nearly 70% of patients who undergo TMS therapy report a significant reduction in their depression symptoms. For some, the improvement is so dramatic that they feel 50 to 100% better by the end of the treatment period.
The ultimate goal of TMS therapy is to provide lasting relief for individuals living with depression. Dr. Jasberg emphasizes the rewarding experience of having an effective treatment option for those who have lost hope. The hope is that with increased awareness and accessibility, more individuals suffering from treatment-resistant depression can find relief and ultimately live happier, healthier lives.
In a world where mental health continues to be a prominent issue, it is essential to explore alternative treatments like TMS and ensure that individuals are aware of all available options. While every person’s journey with depression is unique, the development of new therapies offers hope and renewed possibilities for those who have struggled with treatment-resistant depression.
Living with treatment-resistant depression: Refers to individuals who experience depression that does not respond adequately to standard treatments.
Transcranial magnetic stimulation (TMS): A treatment method that involves delivering magnetic pulses to the brain to stimulate neural circuitry and alleviate symptoms of depression.
Neurotransmitters: Chemical messengers in the brain that transmit signals between nerve cells.
FDA-approved: Refers to the approval granted by the U.S. Food and Drug Administration, indicating that a treatment has been deemed safe and effective for a specific medical condition.
Dr. Suzanna Jasberg: A senior director of adult psychiatry who emphasizes the importance of spreading awareness about TMS.
TMS therapy: Refers to the treatment process that involves daily sessions for six weeks to deliver magnetic pulses to stimulate the brain.
Treatment-resistant depression: Depression that does not respond adequately to standard treatments, such as medications or therapy.
Promising results: Positive and encouraging outcomes observed in individuals undergoing TMS therapy.
A significant reduction in depression symptoms: Refers to a significant decrease in the severity of depressive symptoms experienced by individuals after undergoing TMS therapy.
Lasting relief: The goal of TMS therapy is to provide long-term relief from depression symptoms.
Increased awareness and accessibility: Refers to the need to inform more individuals about TMS therapy and make it more widely available.
Happier, healthier lives: The desired outcome for individuals living with treatment-resistant depression who find relief through TMS therapy.